Joseph ST. LAURENT,Gerald S. Jones,David M. Bresse
申请号：
US15837283
公开号：
US20180353459A1
申请日:
2017.12.11
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a methanesulfonylalkylnitrile compound, or a pharmaceutically acceptable salt or solvate thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering a methanesulfonylalkylnitrile compound or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
